Zobrazeno 1 - 10
of 436
pro vyhledávání: '"James F Burke"'
Autor:
Mousumi Banerjee, James F Burke, Akbar K Waljee, Benjamin Brennan, Beth Wallace, Lindsey B. De Lott, Kevin Kerber, Chloe Roslin, Samuel Terman, Chris Andrews
Publikováno v:
BMJ Open, Vol 14, Iss 7 (2024)
Objective Optic neuritis (ON) is an acute focal inflammation of the optic nerve routinely treated with glucocorticoids. We aimed to compare adverse events (AE) among glucocorticoid-treated and untreated patients in the real world to guide clinical de
Externí odkaz:
https://doaj.org/article/26a5abf25ef24bd4adf04fa8256df07c
Autor:
James F Burke, Luciana L Copeland, Jeremy B Sussman, Rodney A Hayward, Alden L Gross, Emily M Briceño, Rachael Whitney, Bruno J Giordani, Mitchell S V Elkind, Jennifer J Manly, Rebecca F Gottesman, Darrell J Gaskin, Stephen Sidney, Kristine Yaffe, Ralph L Sacco, Susan R Heckbert, Timothy M Hughes, Andrzej T Galecki, Deborah A Levine
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0300005 (2024)
Strategies to prevent or delay Alzheimer's disease and related dementias (AD/ADRD) are urgently needed, and blood pressure (BP) management is a promising strategy. Yet the effects of different BP control strategies across the life course on AD/ADRD a
Externí odkaz:
https://doaj.org/article/b78f6b0ea3e547ca803edd2524e74981
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282658 (2023)
Epilepsy is a common, serious condition. Fortunately, seizure risk decreases with increasing seizure-free time on antiseizure medications (ASMs). Eventually, patients may consider whether to stop ASMs, which requires weighing treatment benefit versus
Externí odkaz:
https://doaj.org/article/03b3b796f030449cb34a79e9f5118beb
Autor:
Samuel W Terman, James F Burke
Publikováno v:
SAGE Open Medicine, Vol 9 (2021)
Objectives: Accurately measuring disability is critical toward policy development, economic analyses, and determining individual-level effects of health interventions. Nationally representative population surveys such as the National Health and Nutri
Externí odkaz:
https://doaj.org/article/fb325c70d5944915807cc4bd23615a4d
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211599 (2019)
BACKGROUND:Neuroimaging for headaches is both common and costly. While the costs are well quantified, little is known about the benefit in terms of diagnosing pathology. Our objective was to determine the role of early neuroimaging in the identificat
Externí odkaz:
https://doaj.org/article/166d59cde8b1475d8f3fe353ada5acf1
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114339 (2014)
OBJECTIVES:In this study, we developed a model of presymptomatic treatment of Alzheimer disease (AD) after a screening diagnostic evaluation and explored the circumstances required for an AD prevention treatment to produce aggregate net population be
Externí odkaz:
https://doaj.org/article/5e5ccda846254c7ab799dcfb38a8efa9
Autor:
Samuel W. Terman, Joshua D. Niznik, Geertruida Slinger, Willem M. Otte, Kees P. J. Braun, Carole E. Aubert, Wesley T. Kerr, Cynthia M. Boyd, James F. Burke
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background For the two-thirds of patients with epilepsy who achieve seizure remission on antiseizure medications (ASMs), patients and clinicians must weigh the pros and cons of long-term ASM treatment. However, little work has evaluated how
Externí odkaz:
https://doaj.org/article/121c1d359fdf418788ccc48abbee6f67
Autor:
Lesli E. Skolarus, Anne E. Sales, Marc A. Zimmerman, Casey L. Corches, Zach Landis-Lewis, Maria Cielito Robles, A. Camille McBride, Narmeen Rehman, Alina Oliver, Nishat Islam, Mellanie V. Springer, Alison O’Brien, Sarah Bailey, Lewis B. Morgenstern, William J. Meurer, James F. Burke
Publikováno v:
Implementation Science, Vol 14, Iss 1, Pp 1-12 (2019)
Abstract Background Post-stroke disability is common, costly, and projected to increase. Acute stroke treatments can substantially reduce post-stroke disability, but few patients take advantage of these cost-effective treatments. Practical, cost-effi
Externí odkaz:
https://doaj.org/article/615c8a3e0358445e829317de9efee9d1
Autor:
Sanne J. den Hartog, Osama Zaidat, Bob Roozenbeek, Adriaan C. G. M. van Es, Agnetha A. E. Bruggeman, Bart J. Emmer, Charles B. L. M. Majoie, Wim H. van Zwam, Ido R. van den Wijngaard, Pieter Jan van Doormaal, Hester F. Lingsma, James F. Burke, Diederik W. J. Dippel
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 7 (2021)
Background First‐pass reperfusion (FPR) is associated with favorable outcome after endovascular treatment. It is unknown whether this effect is independent of patient characteristics and whether FPR has better outcomes compared with excellent reper
Externí odkaz:
https://doaj.org/article/05bb4e38b3244fcd98347815a3e34113
Autor:
Elan L, Guterman, Karl A, Sporer, Thomas B, Newman, Remle P, Crowe, Daniel H, Lowenstein, S Andrew, Josephson, John P, Betjemann, James F, Burke
Publikováno v:
Annals of Emergency Medicine. 80:319-328
Guidelines recommend 10-mg intramuscular midazolam as the first-line treatment option for status epilepticus. However, in real-world practice, it is frequently administered intranasally or intravenously and is dosed lower. Therefore, we used conventi